SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-20-002301
Filing Date
2020-02-26
Accepted
2020-02-26 16:14:04
Documents
90
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrtx-20191231x10k.htm   iXBRL 10-K 1971093
7 EXHIBIT 4.5 mrtx-20191231xex45.htm EX-4.5 14916
8 EXHIBIT 10.16 mrtx-20191231xex1016.htm EX-10.16 22952
9 EXHIBIT 23.1 mrtx-20191231xex231.htm EX-23.1 8885
10 EXHIBIT 31.1 mrtx-20191231xex311.htm EX-31.1 12452
11 EXHIBIT 31.2 mrtx-20191231xex312.htm EX-31.2 13492
12 EXHIBIT 32.1 mrtx-20191231xex321.htm EX-32.1 8189
13 EXHIBIT 21.1 exhibit211.htm EX-21.1 3782
14 EXHIBIT 10.5 mrtx-20191231xex105.htm EX-10.5 68735
15 a5yeartotalreturn123119.jpg GRAPHIC 51882
  Complete submission text file 0001628280-20-002301.txt   8253919

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20191231_lab.xml EX-101.LAB 654009
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20191231_cal.xml EX-101.CAL 72548
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20191231.xsd EX-101.SCH 50710
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20191231_pre.xml EX-101.PRE 377845
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20191231_def.xml EX-101.DEF 200996
91 EXTRACTED XBRL INSTANCE DOCUMENT mrtx-20191231x10k_htm.xml XML 1459909
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35921 | Film No.: 20655826
SIC: 2834 Pharmaceutical Preparations